Market research
MEB.AU Medibio Limited
AU AUD Not available
Latest close
—
—
Loading market data…
Test a moving-average rule with historical data.
Market facts
- Market cap
- Not available
- P/E ratio
- Not available
- Analyst target
- Not available
- Dividend yield
- nan%
- Beta
- Not available
Community
Investor discussion
1 comment
Sign in to join the MEB.AU discussion.
5 years, 5 months ago
Medibio Limited is currently in a long term downtrend where the price is trading 12.4% below its 200 day moving average.
From a valuation standpoint, the stock is 68.3% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 81.6.
Medibio Limited's total revenue rose by 30.4% to $1M since the same quarter in the previous year.
Its net income has increased by 69.0% to $-742K since the same quarter in the previous year.
Finally, its free cash flow grew by 47.3% to $-971K since the same quarter in the previous year.
Based on the above factors, Medibio Limited gets an overall score of 4/5.